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Transcriptome analysis-identified
long noncoding RNA CRNDE
in maintaining endothelial cell
proliferation, migration, and tube
formation
Matthew Moran1, Xiao Cheng1, Mohamed Sham Shihabudeen Haider Ali1, Nishikant Wase1,
Nghi Nguyen1, Weilong Yang2, Chi Zhang2, Concetta DiRusso 1,3 & Xinghui Sun1,4*
Obesity is a leading risk factor for type-2 diabetes. Diabetes often leads to the dysregulation of
angiogenesis, although the mechanism is not fully understood. Previously, long noncoding RNAs
(lncRNAs) have been found to modulate angiogenesis. In this study, we asked how the expression levels
of lncRNAs change in endothelial cells in response to excessive palmitic acid treatment, an obesitylike condition. Bioinformatics analysis revealed that 305 protein-coding transcripts were upregulated
and 70 were downregulated, while 64 lncRNAs were upregulated and 46 were downregulated. Gene
ontology and pathway analysis identified endoplasmic reticulum stress, HIF-1 signaling, and Toll-like
receptor signaling as enriched after palmitic acid treatment. Moreover, we newly report enrichment of
AGE-RAGE signaling pathway in diabetic complications, IL-17 signaling, and cysteine and methionine
metabolism by palmitic acid. One lncRNA, Colorectal Neoplasia Differentially Expressed (CRNDE),
was selected for further investigation. Palmitic acid induces CRNDE expression by 1.9-fold. We
observed that CRNDE knockdown decreases endothelial cell proliferation, migration, and capillary
tube formation. These decreases are synergistic under palmitic acid stress. These data demonstrated
that lncRNA CRNDE is a regulator of endothelial cell proliferation, migration, and tube formation in
response to palmitic acid, and a potential target for therapies treating the complications of obesityinduced diabetes.
Diabetes and obesity have become major health problems throughout the world. As of 2017, approximately
24,710,000 people in the United States had diabetes, with an estimated economic impact of $327 billion1. One of
the major processes dysregulated in diabetes is angiogenesis, i.e., the formation of new capillaries from existing
ones2. One of the major components of angiogenesis is endothelial cells. Endothelial cells line the inner walls of
the blood vessels and form a barrier between the blood and tissues. Angiogenesis begins when endothelial cells
receive pro-angiogenic signals from hypoxic or injured tissues3. In response, endothelial cells migrate through
the tissue following the gradient of angiogenic signals from both sides, proliferating to create a new vessel, until
they fuse and form a new capillary2. A complete picture, however, has yet to be developed of how endothelial cells
function and how they are regulated in obesity that lead to endothelial dysfunction, especially regarding the role
of lncRNAs.
LncRNAs are defined as RNA molecules that are longer than 200 nucleotides and do not code for protein.
They have been shown to affect numerous processes, such as development and tumorogenesis4. LncRNAs, such as
metastasis associated lung adenocarcinoma transcript 1 (MALAT1), MANTIS, myocardial infarction associated
transcript (MIAT) and antisense non-coding RNA in the INK4 locus (ANRIL)5–8, have been found to regulate
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angiogenesis by adopting a variety of roles. Knockdown of the lncRNA MALAT1 causes dysregulated proliferation of endothelial cells and inhibition of recovery from hindlimb ischemia6. MANTIS is a lncRNA found to be
required for transcription of angiogenesis genes, such as SOX18 and SMAD665. MIAT promotes angiogenesis by
acting as a competing endogenous RNA to miR-150-5p8, and ANRIL inhibits angiogenesis through binding to
the Polycomb Repressor Complex 27.
Obesity is a leading risk factor for type 2 diabetes, and it is associated with increasing levels of circulating free
fatty acids, especially palmitic acid9,10. Thus, palmitic acid is often used as an inducer in vitro to mimic obesogenic
conditions present in vivo. Palmitic acid can cause endothelial dysfunction by interfering with normal signaling
pathways. For example, it impairs insulin signaling, eNOS activity, and nitric oxide production by inducing the
activation of IκB-kinase β11 or promoting PTEN activity12. It induces superoxide production through NADPH
oxidase13, which is mediated by Toll-like receptor 414. Recently, it was reported that palmitic acid treatment can
activate the Stimulator of Interferon Genes (STING) by inducing mitochondrial damage and leakage of mitochondrial DNA into the cytosol15. Despite these exciting studies, the transcriptome regulated by palmitic acid in
endothelial cells and the role of lncRNAs in regulating endothelial response to palmitic acid are not completely
understood. In this study, an understanding of the transcriptome was acquired through RNA-seq and a highly
expressed lncRNA, CRNDE, was selected for further study to determine its effects on angiogenesis. It is observed
that palmitic acid upregulates genes involved in stress response and reduces angiogenic function. Also, knockdown of the lncRNA CRNDE inhibits angiogenic potential in endothelial cells.

Results

Analysis of HUVEC transcriptome.

To determine the effect that palmitic acid has on endothelial transcriptome, RNA-seq was performed. Human umbilical vein endothelial cells (HUVECs) were treated with
100 μM palmitic acid and RNA sequencing was performed. After alignment and differential expression analysis,
according to the process outlined in Fig. 1A, principal component analysis of the clusters was performed, and
the palmitic acid treatment and control (fatty acid-free BSA) clustered as expected (Supplementary Fig. 1A).
35.5% of transcripts analyzed are mRNA and 27.4% are lncRNA (Fig. 1B). There were between 60 million and
80 million reads mapped for the samples (Supplementary Table 1). An mRNA was considered as expressed if the
average counts per million (CPM) in one condition (control or PA) was greater than 1. Of the 27.4% mapped as
lncRNA, 53.6% was intergenic lncRNA, which was analyzed further in this study (Fig. 1C). LncRNA was considered expressed if the CPM in one condition was greater than 0.1 to include lncRNAs expressed at low levels
in the analysis as lncRNA expression levels are 10-fold less abundant than mRNAs16. All mRNAs or lncRNAs
that were not found to be expressed were eliminated from the analysis. mRNAs and lncRNAs were considered as
significantly differentially expressed if the fold change of palmitic acid versus control was greater than 1.5 or less
than 0.66 and the p-value was less than 0.05. Analysis based on mapping to individual chromosomes found that
the highest number of differentially expressed mRNAs and lncRNAs were on chromosome 1 (Supplementary
Figs. 1B and 2A). Analysis of the expression levels of the mRNA found that the transcripts which were differentially expressed had a wide range of expression (Fig. 2A). Heatmap analysis of the differentially expressed mRNA
showed 305 protein-coding transcripts upregulated after palmitic acid treatment compared to control, and 70
protein-coding transcripts downregulated (Supplementary Fig. 1C). The top 20 upregulated and 20 downregulated mRNAs were shown in Fig. 2B. We found that the top enriched Kyoto Encyclopedia of Genes and Genomes
(KEGG) pathways in differentially expressed genes were linked to the tumor necrosis factor-α (TNF-α), MAPK,
NF-κB, PPAR, HIF-1 signaling pathways and insulin resistance (Fig. 2C, Table 1). In addition, we discovered
that AGE-RAGE signaling pathway in diabetic complications and IL-17 signaling were enriched, which have
not been reported. Gene Ontology (GO) analysis by Gene Set Enrichment Analysis of genes induced by palmitic acid showed a number of enriched GO terms (Table 2). Palmitic acid induces endoplasmic reticulum (ER)
stress17,18, and this was also shown by being the most enriched GO terms in our RNA-seq (Table 2). Given this,
we examined the effect of CRNDE knockdown on ER stress response genes. CRNDE knockdown reduces the
ER stress response (Supplementary Fig. 1D), as measured by the ER stress response genes DNA damage inducible transcript 3 (DDIT3), PRKR-like endoplasmic reticulum kinase (PERK, also known as eukaryotic initiation
factor 2 alpha kinase 3), X-box binding protein 1 (XBP1) and activating transcription factor-6 (ATF6). These
data suggest that CRNDE is involved in the upregulation of ER stress response genes by palmitic acid. Analysis
of genes reduced by palmitic acid showed enrichment in GO terms such as Wnt protein binding, Wnt activated
receptor activity, transforming growth factor beta binding, and transforming growth factor beta receptor binding (Table 3). Expression level analysis of differentially expressed lncRNAs, using the same fold change cutoff as
mRNA, showed the same range of expression as mRNA, although some of the most highly expressed lncRNA
were not significantly differentially expressed (Fig. 3A). Heatmap analysis of the significantly differentially
expressed lncRNAs showed that 64 lncRNAs were upregulated and 46 downregulated (Supplementary Fig. 2B;
Supplementary Table 3). CRNDE (indicated by the red dot in Fig. 3A) is one of the highest expressed lncRNAs
that was also significantly induced by palmitic acid. The top 20 lncRNAs by expression that are also differentially
expressed were shown in Fig. 3B. Our data shows that the expression of many protein-coding genes and lncRNAs
were changed by palmitic acid in HUVECs.

LncRNA CRNDE expression is induced by palmitic acid in HUVECs. The lncRNA CRNDE was
chosen for further study, since it is highly expressed in HUVECs and its expression was significantly induced
by palmitic acid (Fig. 3B). CPMs for CRNDE are shown in Supplementary Table 2. CRNDE upregulation was
confirmed by qPCR after HUVECs were treated with 100 µM palmitic acid. After 12 hours, CRNDE was significantly upregulated by 1.9-fold (Fig. 3C). HMOX1 and VEGF-A, which are well known genes involved in angiogenesis19,20, were also analyzed to compare the relative expression of CRNDE with them (Fig. 3C). To examine
the mechanisms underlying CRNDE induction by palmitic acid in HUVECs, the proximal promoter of CRNDE
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Figure 1. Distribution of RNA-seq data. (A) Analysis workflow for RNA-seq data. (B) Percentage of the
different types of RNA identified by RNA-seq. (C) Percentages of the different types of lncRNA identified in (B).

was cloned into luciferase reporter (Supplementary Fig. 3). The CRNDE promoter was defined as a sequence of
1761 nucleotides surrounding the transcription start site encompassing 1718 nucleotides upstream of the Crnde
gene and 43 nucleotides of 5′ Crnde gene. The luciferase activities were increased by 8.1-fold in the presence of
CRNDE promoter, indicating CRNDE promoter indeed activates luciferase expression. However, the luciferase
activities driven by CRNDE promoter were not further increased in HUVECs by palmitic acid treatment compared with control, suggesting a distal cis-sequence mediates CRNDE induction by palmitic acid. Given the effect
of palmitic acid upregulating NF-κB signaling, it was unknown whether palmitic acid induces CRNDE expression
through NF-κB signaling. HUVECs were treated with TNF-α to activate NF-κB signaling, then the expression
of CRNDE expression was examined by qPCR. It turned out the CRNDE expression was not TNF-α-responsive
(Supplementary Fig. 4), suggesting the induction of CRNDE by palmitic acid is not likely mediated by palmitic
acid-activated NF-κB signaling.

CRNDE knockdown inhibits angiogenic potential.

To determine the effect of CRNDE on endothelial cells, functional assays were performed. Lentiviral shRNA against CRNDE (shCRNDE) was used to knock
down CRNDE expression, and endothelial cell proliferation, migration, and angiogenic activity were measured.
CRNDE expression was reduced by 87.5% in HUVECs transduced with lentiviral shCRNDE (Supplementary
Fig. 5). CRNDE knockdown reduces the wound closure by 27.1% in the scratch-wound assay (Fig. 4A,B), indicating CRNDE knockdown inhibits cell migration. As a measure of angiogenic activity, a Matrigel capillary-like
tube formation assay21 was performed (Fig. 4C–E). After 6 h, total tube length, nodes and segments were reduced
by 57.7%, 87.2% and 85.5%, respectively, in HUVECs transduced with lentiviral shCRNDE than in HUVECs
transduced with lentiviral control shRNA, indicating that CRNDE knockdown has an inhibitory effect on the
capacity of HUVECS to form capillary-like tube structures. The effects of CRNDE knockdown on cell cycle were
examined by propidium iodide staining followed by flow cytometry analysis (Fig. 5A,B). The percentage of cells
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Figure 2. Differentially expressed mRNAs. (A) Expression plot of identified mRNAs. Expression is determined
by average FPKM. Blue are those mRNAs significantly differentially expressed. (B) Heatmap of the top 20
upregulated and top 20 downregulated mRNAs. Data was plotted as z-score of the log2 fold change. (C) Highly
enriched KEGG pathways from differentially expressed genes. Protein coding genes are identified by gene
symbols.
in S phase is 8.9% after CRNDE knockdown compared with 23.9% in control cells. In contrast, the percentage
of cells in G1 phage is 81.2% compared with 57.9% in control cells. These data suggest that CRNDE knockdown
inhibits cell proliferation. We examined the expression of cyclin kinase inhibitor p21 by western blot analysis and
found the CRNDE knockdown increases p21 expression by 1.7-fold (Fig. 5C, Supplementary Fig. 6). These data
demonstrate that CRNDE knockdown inhibits the angiogenic potential of HUVECs.

CRNDE is involved in the response to palmitic acid. Having established that CRNDE is involved in
angiogenesis, the role of CRNDE on angiogenesis under palmitic acid stress was determined by performing
scratch and tube formation assays (Fig. 6). HUVECs were transduced with shCRNDE and treated with palmitic
acid for 12 h, and then the assays were performed. In the scratch-wound assay, palmitic acid treatment reduces
wound closure by 59.6% (Fig. 6A,B), which is consistent with a previous study22. CRNDE knockdown reduces
wound closure by 44.0% in control HUVECs (Fig. 6A,B). Importantly, CRNDE knockdown and palmitic acid
treatment have synergistic effects on wound closure, which was reduced by 74.6%. In the capillary-like tube
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Pathway

No. of genes

FDR

TNF signaling pathway

18/110

2.13 × 10−8

Rheumatoid arthritis

11/91

8.02 × 10−4

Biosynthesis of amino acids

10/75

8.02 × 10−4

AGE-RAGE signaling pathway in diabetic complications

11/100

1.41 × 10−3

MAPK signaling pathway

19/295

3.70 × 10−3

NF-kappa B signaling pathway

10/100

4.69 × 10−3

Transcriptional misregulation in cancer

14/186

4.69 × 10−3

Glycine, serine and threonine metabolism

6/40

9.15 × 10−3

IL-17 signaling pathway

9/93

9.15 × 10−3

PPAR signaling pathway

8/76

9.84 × 10−3

Fluid shear stress and atherosclerosis

11/139

1.00 × 10−2

HIF-1 signaling pathway

9/100

1.17 × 10−2

Cysteine and methionine metabolism

6/49

1.67 × 10−2

Insulin resistance

9/108

1.67 × 10−2

One carbon pool by folate

4/20

1.67 × 10−2

Ras signaling pathway

14/232

1.90 × 10−2

Rap1 signaling pathway

13/208

1.92 × 10−2

Kaposi sarcoma-associated herpesvirus infection

12/186

2.10 × 10−2

Amoebiasis

8/95

2.26 × 10−2

Ferroptosis

5/40

2.75 × 10−2

Table 1. Enriched KEGG pathways in differentially expressed genes. No. of genes is reported as the number of
genes in the pathway identified as differentially expressed in this data set versus the total number of genes in the
pathway.

Category

Biological Process

Cellular Component

Metabolic Function

Name

No. of Genes

FDR

Intrinsic Apoptotic Signaling Pathway in Response to Endoplasmic
30/32
Reticulum Stress

1.03 × 10−4

Response to Endoplasmic Reticulum Stress

196/233

7.81 × 10−4

Decidualization

14/21

1.91 × 10−3

Cellular Response to Topologically Incorrect Protein

99/122

1.98 × 10−3

Positive Regulation of Transcription From RNA Polymerase II
Promoter umn Response to Stress

18/23

3.03 × 10−3

Nuclear Nucleosome

30/41

5.20 × 10−3

DNA Packaging Complex

79/108

7.01 × 10−3

Anchored Component of Membrane

38/152

6.65 × 10−2

Nuclear Euchromatin

20/24

1.21 × 10−1

Pre Autophagosomal Structure

25/31

1.32 × 10−1

Amino Acid Transmembrane Transporter Activity

39/79

2.85 × 10−3

Hormone Activity

16/119

6.59 × 10−3

L Amino Acid Transmembrane Transporter Activity

31/54

1.01 × 10−2

Anion Cation Symporter Activity

17/53

1.85 × 10−2

LRR Domain Binding

14/17

2.01 × 10−2

Table 2. Top 5 Gene Ontology terms from each category enriched in genes upregulated by palmitic acid. No. of
genes is reported as the number of genes in the term identified as differentially expressed in this data set versus
the total number of genes in the term.

formation assay, palmitic acid treatment reduces tube length by 35.4% in shNT-treated cells (Fig. 6C,D), which is
consistent with what previously reported22. In addition, palmitic acid treatment reduces the number of segments
and number of nodes by 47.7% and 35.5%, respectively (Fig. 6C,D). CRNDE knockdown reduces tube length by
51.3%, the number of segments by 67.7%, and the number of nodes by 56.3% in control HUVECs (Fig. 6C,D).
Similarly, CRNDE knockdown and palmitic acid treatment have synergistic effects on capillary-like tube formation. CRNDE knockdown reduces the tube length, the number of segments, and the number of nodes by 71.6%,
80.6%, and 70.6%, respectively, in HUVECs treated with palmitic acid compared with shNT-treated cells under
control condition (Fig. 6C,D). CRNDE knockdown also reduces branching by 23.4% and 43.2% under control and
palmitic acid conditions, respectively; palmitic does not reduce branching in shNT-treated cells (Fig. 6E). Human
aortic endothelial cells (HAECs) showed a similar trend in some respects (Supplementary Fig. 7). CRNDE knockdown reduced wound closure by 43.5% under control condition. It also reduced the number of nodes and the
Scientific Reports |
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Category

Biological Process

Cellular Component

Metabolic Function

Name

No. of Genes

FDR

Spliceosomal snRNP Assembly

33/38

8.47 × 10−2

Maturation of SSU rRNA

39/42

1.23 × 10−1

Nucleobase Metabolic Process

30/39

1.33 × 10−1

Nucleobase Biosynthetic Process

18/18

1.49 × 10−1

Regulation of Heart Morphogenesis

16/29

1.58 × 10−1

Small Subunit Processome

30/33

8.07 × 10−2

Preribosome

54/61

9.26 × 10−2

Small Nucleolar Ribonucleoprotein Complex

18/20

9.46 × 10−2

SMN Sm Protein Complex

17/17

1.12 × 10−1

Nucleolar Part

56/62

1.52 × 10−1

Wnt Protein Binding

16/31

2.06 × 10−1

Nucleosomal DNA Binding

28/30

2.09 × 10−1

Wnt Activated Receptor Activity

13/22

2.23 × 10−1

Transforming Growth Factor Beta Binding

15/16

2.32 × 10−1

Transforming Growth Factor Beta Receptor Binding

27/50

2.39 × 10−1

Table 3. Top 5 Gene Ontology terms from each category enriched in genes downregulated by palmitic acid.
No. of genes is reported as the number of genes in the term identified as differentially expressed in this data set
versus the total number of genes in the term.

number of segments by 16.3% and 22% respectively (Supplementary Fig. 7). Tube length and branching were
not significantly reduced. Palmitic acid reduced wound closure by 68.6% and tube length, the number of nodes,
the number of segments and branching by 25.9%, 57.6%, 73.6% and 34.2% respectively in shNT-treated cells
(Supplementary Fig. 7). Surprisingly, overexpressing CRNDE 87.1-fold (Supplementary Fig. 8) did not produce
the opposite effect when examined by the scratch-wound and tubule formation assays (Supplementary Fig. 9).
CRNDE overexpression reduces tube length, the number of segments, the number of nodes and branching by
13.3%, 21.7%, 27.2%, and 27.8% respectively (Supplementary Fig. 9). When CRNDE overexpressing HUVECs are
treated with palmitic acid, wound closure is reduced by 73.1% compared to control cells (Supplementary Fig. 9).
Tube length, the number of segments, the number of nodes and branching are reduced by 28.3%, 38.7%, 28.4%
and 32.6% respectively (Supplementary Fig. 9). Our data imply that the induction of CRNDE by palmitic acid
may counteract the effects of palmitic acid on endothelial cells.

Discussion

In this study, changes in the transcriptome of HUVECs induced by palmitic acid were identified by RNA-seq, and
the lncRNA CRNDE is shown to maintain angiogenic potential of HUVECs. CRNDE has already been identified
as regulating metabolic pathways in cancer, but its role in diseases other than cancer has not been established.
One way in which CRNDE is involved in regulating metabolism is in colorectal cancer, being downregulated by
insulin in an AKT and MAPK dependent manner23. The loss-of-function studies demonstrated that CRNDE
expression promotes the metabolic changes by which cancer cells switch to aerobic glycolysis23. CRNDE has also
been identified as an oncogene, activating the Wnt signaling pathway in breast cancer by sponging miR-13624.
Other than cancer, CRNDE is required for platelet‐derived growth factor‐BB-stimulated proliferation and migration of vascular smooth muscle cells25, and it inhibits the transcriptional activation of Smad3 on target genes in
cardiac fibroblasts26. In our studies, we found that CRNDE knockdown reduces endothelial cell migration, proliferation, and capillary-like tube formation (Figs. 4–6). These data suggest that CRNDE is an important regulator
of various cellular functions in different cell types and may be a potential drug target. LncRNAs can be targeted
by drugs to cause degradation, just as they are knocked down in vitro and in vivo. One such mechanism is the use
of chemically modified antisense oligonucleotides. One form of antisense oligonucleotides, a gapmeR, consists
of two spans of modified ribonucleotides connected by an antisense DNA linker that recruits RNse H to degrade
the target RNA27,28. GapmeRs have been successfully used to knock down lncRNA in vitro and in vivo29–31.
One gapmeR, mipomersen, has been approved for familial hypercholesterolemia32.
Our transcriptome analysis by RNA-seq revealed that the expression of hundreds of transcripts including
mRNAs and lncRNAs is changed by palmitic acid in HUVECs (Figs. 1–3). Gene ontology analysis also shows that
palmitic acid induces endoplasmic reticulum stress (Table 2). Palmitic acid also reduces endothelial cell proliferation and migration through activating the cGAS/STING signaling pathway, a marker of mitochondrial damage22. Interestingly, CRNDE knockdown reduces ER stress related genes (Supplementary Fig. 1D). Endoplasmic
reticulum stress and oxidative stress are linked in endothelial cells33, and oxidative stress can induce JAK-STAT
signaling34. CRNDE can also induce JAK-STAT in fibroblasts after lipopolysaccharide challenge35. Given this,
the possible connection between palmitic acid induced endoplasmic reticulum stress and CRNDE induction
needs to be examined in future studies, providing a possible mechanism by which CRNDE expression is induced
after palmitic acid challenge. Given that in HUVECs, CRNDE knockdown reduced endothelial cell proliferation and migration more than palmitic acid alone (Fig. 6), but CRNDE is not directly induced by palmitic acid
(Supplementary Fig. 3), CRNDE may act as a compensatory mechanism to preserve some angiogenic ability
after palmitic acid treatment. Palmitic acid induces other compensatory mechanisms, such as causing induction
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Figure 3. Differentially expressed lncRNAs. (A) Expression plot of identified lncRNAs. Expression is
determined by average FPKM. Blue and red are those lncRNAs significantly differentially expressed; red is
CRNDE. (B) Heatmap of the top 20 lncRNAs by expression that are differentially expressed. Data was plotted
and ranked as z-score of the log2 fold change. (C) Effect of palmitic acid on gene expression. HUVECs were
treated with palmitic acid or vehicle control for 12 hours. The expression of CRNDE, HMOX1, and VEGF-A
was analyzed by RT-qPCR, *p < 0.05, **p < 0.001.

of HMOX1 (heme oxygenase 1) in neuroblastoma cells to deal with the increased oxidative stress palmitic acid
causes36. Indeed, in this study, HMOX1 is induced by palmitic acid (Figs. 2B and 3C).
The molecular basis by which CRNDE knockdown inhibits angiogenic potential in endothelial cells remains
unknown. CRNDE promotes proliferation and migration of trophoblasts by acting as a competing endogenous
RNA for miR-1277, and its knockdown reduces proliferation and migration37. Given this, CRNDE may also affect
endothelial cell proliferation and migration through effecting miRNA levels. When CRNDE is knocked down,
there is a reduction in endothelial cell proliferation, and the cell cycle arrests in the G1 phase (Figs. 5 and 6).
This is associated with an increase in p21 expression (Fig. 5C). This is consistent with a previous study showing
that CRNDE silencing induces the expression of p21 in colorectal cancer cells38. Thus, increased p21 expression
may mediate the effects of CRNDE knockdown on endothelial cell migration, proliferation, and capillary tube
formation in HUVECs. Finally, CRNDE overexpression did not have an opposite effect to CRNDE knockdown
on endothelial cell proliferation and tube formation (Supplementary Fig. 9), indicating that CRNDE is necessary
but not sufficient for the induction of these processes. The CRNDE overexpression results suggest additional
cofactors are required to facilitate CRNDE function. While the mechanism of CRNDE’s action in endothelial
cells is unknown, CRNDE has the potential to be a novel target in the fight against the angiogenic complications
of diabetes and obesity.
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Figure 4. CRNDE knockdown inhibits endothelial cell proliferation and tube formation. (A) CRNDE
knockdown reduces wound closure in HUVECs. CRNDE was treated with CRNDE shRNA (shCRNDE)
or non-targeting control shRNA (shNT) for 24 h before wounding. Images were taken from fixed cells 12 h
after wounding. Representative images of 3 independent experiments were shown. Scale bars are 500 µm.
(B) Quantification of wound closure, *p = 0.027. (C) CRNDE knockdown reduces tube formation. HUVECs
were treated as in a before being seeded into Matrigel-coated wells. Images were taken from fixed wells after
6 hours. Representative images of 3 independent experiments were shown. (D) Quantification of tube length in
millimeters *p = 3.2 * 10−6. (E) Quantification of number of segments (*p = 9.9 * 10−4) and number of nodes
(*p = 6.5 * 10−4).

Methods

All methods reported here were carried out in accordance with relevant guidelines and regulations of the
University of Nebraska - Lincoln. All experimental protocols were reviewed and approved by the University of
Nebraska - Lincoln Institutional Biosafety Committee (Protocol Number: IBC788). The studies in the paper did
not involve human tissue samples or human subjects. There are no studies in the manuscript that require ethical
approval.

Cell culture.

HUVECs from pooled donors (Cat. No. CC-2519) and Human Aortic Endothelial Cells
(HAECs) (Cat. No. CC-2535) were purchased from Lonza and cultured in either EGM-2 (Lonza Cat. No.
CC-3162) for RNA-seq experiments or Endothelial Cell Growth Medium (ATCC Cat. No. PCS-100-041) supplemented with 1% penicillin-streptomycin for all other experiments. Media was changed every two days during
normal passaging. All cells used were between passages 3 and 8. In the tubule formation assay, Endothelial Cell
Basal Medium (PromoCell Cat. No. C-22211; hereafter PromoCell EBM) was used where indicated. Cell detachment was carried out with 0.05% trypsin in EDTA (Thermo Fisher). All the experiments were done using three
different lots of HUVECs.
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Figure 5. CRNDE knockdown inhibits the progression of cell cycle. (A) Histogram of DNA content in
HUVECs after CRNDE knockdown. HUVECs were treated with shNT or shCRNDE and then stained with
propidium iodide. DNA content was measured by flow cytometry at 488 nm. Representative histograms of three
independent experiments were shown. (B) Quantification of cell cycle phase in three independent experiments,
*p < 0.05. (C) Western blot analysis of p21 expression and quantification of three independent experiments
(*p = 1.4 * 10−3).

RNA sequencing and analysis. HUVECs were treated for 8 h with 100 µM palmitic acid (NuChuk Prep.)

conjugated to fatty-acid poor BSA (EMD Millipore) in a 3 to 1 molar ratio as previously described11. RNA was
harvested and rRNA depleted, adaptors were ligated, and the samples sent for sequencing on an Illumina HiSeq
2500. After obtaining raw reads, FastQC was used to analyze the quality of the reads. Tophat2 and bowtie39–41
were used to map the reads to the genome, GRCh38 (Ensembl release 8242), and cufflinks43 was used to determine transcript expression. Cuffdiff44 was used to generate FPKM values and edgeR45–48 was used for differential
expression analysis. To determine differential expression, the fold change values were transformed by log2 and
compared against the log2 fold change values from edgeR, that had a requisite p-Value (less than 0.05). Heatmaps
were generated using the R pheatmap package. For Fig. 3B, gene names were taken from Ensembl Release 97,
eliminating from Supplementary Table 3 those IDs which have been removed from release 97.

KEGG pathway analysis.

All significantly differentially expressed genes were used for KEGG pathway
enrichment analysis. Using the biological id translator function from R clusterProfiler package49, Ensembl IDs
were converted to NCBI gene IDs and used for KEGG pathway enrichment analysis. First KEGG pathway enrichment analysis was performed using human metabolic network as a background. P-value cut-off was set at 0.05
and Bonferroni-Hochberg adjustment was performed with minimum gene set (GS) size set to 10 and max GS to
500. Finally, KEGG pathway enrichment data was used to generate plots showing linkages of gene and enriched
KEGG pathways. The edges of the nodes for reduced genes were manually highlighted with black lines.

Scientific Reports |

(2019) 9:19548 | https://doi.org/10.1038/s41598-019-56030-9

9

www.nature.com/scientificreports/

www.nature.com/scientificreports

Figure 6. CRNDE knockdown potentiates the inhibitory effects of palmitic acid on endothelial cell migration
and tube formation. (A) CRNDE knockdown potentiates the inhibitory effects of palmitic acid on wound
closure. HUVECs were treated with shNT or shCRNDE for 24 h and then palmitic acid or vehicle control for
12 h before wounding. Images were taken from fixed cells 12 h after wounding. Representative images of 3
independent experiments were shown. Scale bars are 500 µm. (B) Quantification of (A) (*p < 0.001).
(C) CRNDE knockdown potentiates the inhibitory effects of palmitic acid on tube formation. HUVECs were
treated as for wound healing before being seeded into Matrigel-coated wells. Images were taken from fixed
wells after 6 h. Representative images of 3 independent experiments were shown. (D) Quantification of tube
formation in (C). Tube length in millimeters, the number of segments, and the number of nodes (*p < 0.05,
**p < 0.01, ***p < 1 * 10−4). (E) Quantification of tube formation in (C). Number of branches (*p < 0.05,
**p < 0.001, ***p < 1 * 10−4).

Gene ontology analysis.

Differentially expressed mRNAs were analyzed by Genome Set Enrichment
Analysis as described previously50. GSEA was used to perform Gene Ontology analysis. Enriched terms were
reported in upregulated and downregulated genes. To determine differentially enriched gene ontology terms, a
false discovery rate of 0.25 was used as a cutoff.
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CRNDE shRNA lentiviral generation and HUVEC transduction.

The shRNA target sequence
GTGTGATGCTTCCATAATACA was cloned into the vector pLKO.1-TRC, a gift from David Root (Addgene
plasmid No. 10878) to create shCRNDE. HEK-293T cells were cultured in DMEM supplemented with 10% fetal
bovine serum and penicillin/streptomycin (Thermo Fisher). Lentivirus was produced by transfecting HEK-293T
cells with the CRNDE-pLKO.1 plasmid using Lipofectamine 2000 (Thermo Fisher). After 24 h transfection,
media was collected at 48 h and 72 h post transfection. HUVECs were plated into 12 well plates (100,000 cells/
well) and transduced with the appropriate volume of virus to knock down CRNDE. 24 hours post transduction
media was changed for downstream applications.

Reverse transcription quantitative PCR. RNA was collected from HUVECs and precipitated using
TRIzol Reagent (Thermo Fisher Cat. No. 15596026) according to the manufacturer’s instructions. 1 μg of RNA
was converted to cDNA using the High Capacity cDNA Reverse Transcription Kit (Thermo Fisher Cat. No.
4368813). qPCR was conducted in the CFX Connect Real Time System (BioRad) using 2x Sybr Green qPCR
Master Mix (Bimake Cat. No. B21203). Data was normalized by the DeltaDeltaCt method51. The primers for
qPCR are in Supplementary Table 4.
Scratch assay. HUVECs or HAECs were transduced with CRNDE shRNA (shCRNDE) or a non-targeting
control shRNA (shNT) for 24 h and then seeded into 2 wells of a 6-well plate per condition at 600,000 cells per
well. After resting for 12 h, cells were treated with or without palmitic acid (100 or 200 μM) for 12 h. After treatment 2 wounds were produced per confluent well and images were obtained. After wound formation, wells were
fixed with 2% formaldehyde and images were again taken in the same places. The wound area was measured with
ImageJ and the percentage wound closure was calculated by measuring the area of the wound.
Tube formation assay.

The tubule formation assay was performed as previously described, with slight
modifications21. HUVECs or HAECs were transduced as in the scratch assay and then seeded into one well of a
6-well plate at 300,000 cells per well. After 12 h, cells were treated with or without palmitic acid (100 or 200 μM)
for 12 h. Cells were then trypsinized and neutralized with PromoCell EBM supplemented with 1% FBS. After
centrifugation, HUVECs were resuspended in EBM without FBS and seeded into Matrigel (Corning Cat. No.
254234) coated wells (50 μl per well) at 15,000 cells per well. After 3–6 h, cells were fixed with 4% formaldehyde
and 4–6 random images were taken per well, with duplicate wells per condition. Images were then analyzed with
ImageJ using the Angiogenesis Analyzer plugin by Giles Carpentier (http://imagej.nih.gov/ij/macros/toolsets/
Angiogenesis%20Analyzer.txt), and total branching length, number of nodes and number of segments were used
as markers of angiogenic tube formation.

Flow cytometry.

HUVECs were treated with shCRNDE or shNT for 24 h. 24 h later, cells were fixed in 70%
ethanol at 4 °C with a concentration less than 1 × 106 cells per sample. After fixation, cells were treated with
200 μg/ml RNase A and stained with propidium iodide at a final concentration of 10 μg/ml. Cells were then analyzed using the DxP10 FACsort (BD). Data was analyzed using the FlowJo software (BD).

Western blot.

HUVECs were treated with shCRNDE or shNT for 24 h. 24 h later, cells were lysed in radioimmunoprecipitation buffer (25 mM Tris-HCl pH 7.6, 150 mM NaCl, 1% NP-40, 1% sodium deoxycholate, 0.1%
SDS), and protein concentration determined with the Pierce BCA Protein Assay Kit (Thermo Fisher). 10 µg of
protein was loaded per sample and the samples were separated by SDS-PAGE using a 12% acrylamide gel. After
SDS-PAGE, the samples were transferred to a polyvinylidene fluoride membrane using the Trans Blot Turbo
Transfer System (BioRad; 25 V, 1.0 A, 30 min). After blocking with 5% nonfat milk in TBST, rabbit anti-p21 (Cell
Signaling Technology Cat. No. 2974) was used to probe for p21. Then the blot was probed with HRP-conjugated
anti-rabbit (Cell Signaling Technology Cat. No. 7074) and the signal was detected by chemiluminescence using
the LiCOR Odyssey Fc Imaging System. The blot was stripped using an SDS-glycine stripping buffer (1.5% glycine, 0.1% SDS, 1% Tween 20) and re-probed with rabbit anti-GAPDH (Cell Signaling Technology Cat. No. 2118).
GAPDH was detected in the same way as p21.

Statistical analysis. All experimental data is the average of three independent experiments, reported as
mean ± standard error, unless otherwise stated. All statistical analysis was carried out using two-tailed Student’s
t-test with an alpha level of 0.05. All comparisons were to the control, unless otherwise stated.

Data availability

The RNA-seq data generated in this manuscript is available through the Gene Expression Omnibus52 (GSE141126):
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc = GSE141126.
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